AMPLATZER PFO OCCLUDER
Report
- Report Number
- 2135147-2021-00311
- Event Type
- Injury
- Date Received
- August 4, 2021
- Date of Event
- July 14, 2021
- Report Date
- September 14, 2021
- Manufacturer
- ABBOTT MEDICAL
- Product Code
- MLV
- PMA / PMN Number
- P120021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- PHYSICIAN
Narratives
CORRECTION: UPON REVIEW, THE AMPLATZER PFO OCCLUDER UNDER MANUFACTURING REPORT NUMBER 2135147-2021-00311 SHOULD NOT HAVE BEEN SUBMITTED AS A MEDICAL DEVICE REPORT (MDR) AS THE EVENT DID NOT INDICATE A MALFUNCTION CAUSED A SERIOUS EVENT.
IT WAS REPORTED THAT IN 2018, A 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED IN A SMALL ATRIAL SEPTAL DEFECT (ASD) NEAR THE PATENT FORAMEN OVALE (PFO). ON AN UNKNOWN DATE, RESIDUAL LEAK WAS OBSERVED FROM THE PFO. THEREFORE, ON (B(6) 2021, A SECOND 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED BESIDE THE FIRST OCCLUDER WITH RESOLUTION OF THE RESIDUAL LEAK. THE PATIENT WAS HEMODYNAMICALLY STABLE THROUGHOUT THE PROCEDURE AND WAS REPORTED TO BE IN STABLE CONDITION POST-OPERATIVELY.
THE RESULTS/METHOD AND CONCLUSION CODES ALONG WITH INVESTIGATION RESULTS WILL BE PROVIDED IN A SUBSEQUENT SUBMISSION.
IT WAS REPORTED THAT IN 2018, A 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED IN A SMALL ATRIAL SEPTAL DEFECT (ASD) NEAR THE PATENT FORAMEN OVALE (PFO). ON AN UNKNOWN DATE, RESIDUAL LEAK WAS OBSERVED. THEREFORE, ON (B)(6) 2021, A SECOND 25MM AMPLATZER PFO OCCLUDER WAS IMPLANTED BESIDE THE FIRST OCCLUDER WITH RESOLUTION OF THE RESIDUAL LEAK. THE PATIENT WAS HEMODYNAMICALLY STABLE THROUGHOUT THE PROCEDURE AND WAS REPORTED TO BE IN STABLE CONDITION POST-OPERATIVELY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1169859 | AMPLATZER PFO OCCLUDER | TRANSCATHETER SEPTAL OCCLUDER | MLV | ABBOTT MEDICAL | 9-PFO-025 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Hospitalization| R |